# Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

> **NCT00752596** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 1 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Azimilide 2HCl

## Key facts

- **NCT ID:** NCT00752596
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752596, "Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00752596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*